An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for NOVAVAX Inc
| Ticker | NVAX |
| FIGI | BBG000NVSBL7 |
| CUSIP | 670002401 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 214 / 3.1% |
| Percentage held by institutional investors | 100.0% |
About
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. Wikipedia